No Causal Association Seen for Meniere Disease, Migraine
By Elana Gotkine HealthDay Reporter
MONDAY, June 3, 2024 -- Migraine is not a risk factor for Meniere disease (MD), nor is MD a risk factor for migraine, according to a study published online May 8 in Frontiers in Neurology.
Kangjia Zhang, from The Second Xiangya Hospital of Central South University in Changsha, China, and colleagues used Mendelian random (MR) analysis to examine the potential causal relationship between migraine and MD. Single-nucleotide polymorphisms were extracted from large-scale genome-wide association studies involving European individuals. Effect estimates were mainly evaluated using inverse-variance weighting (IVW).
The researchers did not find a discernable causative link between genetic vulnerability to MD and migraine. In the random-effects IVW method, migraine did not increase the prevalence of MD. Results were largely consistent in an extra weighted median analysis, MR-Egger, Simple mode, and Weighted mode. In the random-effects IVW method, MD did not increase the prevalence of migraine, with similar results seen in the extra weighted median analysis, MR-Egger, Simple mode, and Weighted mode.
"There is a dearth of data regarding the various subgroups of migraine and MD," the authors write. "To facilitate both disease diagnosis and thorough treatment of various disease classifications, our clinical observation study must classify these two diseases in depth."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Endolymphatic Sac Decompression Effective for Vertigo, Migraine
WEDNESDAY, May 28, 2025 -- For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and...
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
WEDNESDAY, May 21, 2025 -- Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do...
Ubrogepant During Prodromal Phase of Migraine Eases Symptoms
TUESDAY, May 13, 2025 -- Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to a study published online May 12 in Nature...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.